• Head_banner_01

EPTIFIBABATIDE Treatment de acutus coronarius syndrome 188627-80-7

Short description:

Nomen: EPTIFIBATIDE

Cas Number: 188627-80-7

Molecular Formula: C35H49N11O9S2

M. pondus: 831,96

Einecs Number: 641-366-7

Density: 1.60 ± 0.1 G / CM3 (praedicta)

Repono conditionibus: Signatum in sicco, copia in freezer, sub -15 ° C


Product Detail

Product Tags

Product Detail

Nomen Eptifibatide
Cas numerum 188627-80-7
MOLECULA C35h49n11o9s2
Pondus 831,96
Einecs numerum 641-366-7
Densitas 1.60 ± 0.1 G / CM3 (praedicta)
Conditions repono Signatum in sicco, copia in freezer, sub -15 ° C

Synonyma

Eptifibatideacetatesalt, EPTIFIBABATIDE, MPA-Har-Gly-ASP, TRP-Pro-CYS-NH2, MPAHARGDWPC, LYNO-NH2, PRO-CYSTFIBANTE, NH2 (Aminoimi nomethyl) -n2- (III-Mercapto-I-oxopropyl, l-l-l-la-la-cystophyl,-L-L-L-Cysteinamide, Mpa-Har-Gly-ASP, TRP-CYS-, CYS1, CYS6).

Platetelet Glycoprotein Anagonist

Etifibatide (Integilin) ​​is a novae polypeptide platelet glycoprotein iib / IIia receptor Anagonist, quod inhibits platelet aggregatio et thrombosis perhibendis in novissimis communis via platelet aggregatio. Comparari cum Monoclonal antibody ABCIXIMAB, Eptifibatide habet fortior, magis directional et specifica binding to GPIIB / IIia debitum ad esse unum conservativum amino acidum substitutione, lysine reponere arginine. Ideo debet habere bonum therapeutica effectus in interventional curatio acuti coronarius syndrome. Platelet glycoprotein iib / IIia receptor antagonist medicaménta sunt developed multum, et currently sunt III species ex apparatu, quod potest esse in orci internationally, ABCIXIMAB, EPTIFIBABABABABABABABABABANT, et Tirofiban. ). Est parum experientia in usum platelet glycoprotein gpiib / IIia receptor Anagonists in Sina, et available pharmaca sunt nimis limited. Tantum unum medicamento, Tirofiban hydrochloride est in foro. Ideo novum platelet glycoprotein iib erat developed. / Iijia receptor antagonos imperative. Domesticis Eptifibatide est imitatio productum produci by Chengdu Pinus Biological Products Co., Ltd.

Pario

Classification Antriplaet Aggregatio Medicamenta

Antiplatet aggregatio medicinae potest esse roughly dividitur in tres genera: I. Cyclooxygenase, I (Cox-I) inhibitors, ut aspirin. II. Inhibere platelet aggregatum adductus a adenosine diphosphate (ADP), ut clopideogrel, prasugrel, Crengrelor, ticagrote, etc. III, tirofiban, ut ABCIXIMAB, EPTIKST, Tirofiban, ut ABCEBIMAB, EPTIFIBANTE, Tiro EP3 Receptor inhibitors, nuper synthesized chemica components et effective excerpta a traditional Seres medicina.


  • Previous:
  • Next:

  • Scribere nuntium hic mitte nobis